Bladder Cancer
📧 Sign up to get email alerts when something new happens for Bladder Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Virtual Histology of the Bladder Wall for Bladder Cancer Staging [EARLY_Phase 1]
This early-phase 1 trial update describes using virtual histology of the bladder wall to stage bladder cancer and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-15Clinical Trial Update: A Study to Compare the Results of FGFR Testing by Either ctDNA Blood Testing or Standard Tumor Tissue Testing
A clinical study comparing FGFR testing results obtained from ctDNA blood testing to standard tumor tissue testing in metastatic bladder can…
-
CLINICAL_TRIALS research · 2025-12-15Clinical Trial Update: Chlorhexidine Antiseptic Irrigation of the Bowel Segment During Radical Cystectomy and Urinary Diversion [NA]
A clinical trial evaluating chlorhexidine antiseptic irrigation of the bowel segment during radical cystectomy with urinary diversion for bl…
-
CLINICAL_TRIALS research · 2025-12-15Clinical Trial Update: Evaluation of the Clinical Utility of Online Adaptive Radiotherapy in Bladder Cancer (BLADAPT-GETUG V11) [NA]
A clinical trial evaluating the clinical utility of online adaptive radiotherapy in bladder cancer; the study is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-12-11Clinical Trial Update: Neoadjuvant Immunotherapy Combined With the Anti-GDF-15 Antibody Visugromab to Treat Muscle Invasive Bladder Cancer [Phase 2]
This Phase 2 neoadjuvant trial evaluates Visugromab, an anti-GDF-15 antibody, in combination with immunotherapy for muscle-invasive bladder …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-09Clinical Trial Update: The Role of Preoperative Immunonutrition on Morbidity and Immune Response After Cystectomy (INCyst Trial) [Phase 3]
The INCyst Phase 3 trial is investigating whether preoperative immunonutrition affects postoperative morbidity and immune response after cys…
-
CLINICAL_TRIALS research · 2025-12-09Clinical Trial Update: Bladder Perfusion of Plasma-Activated Saline for Bladder Cancer [EARLY_Phase 1]
Clinical trial update: a Phase 1 study evaluating bladder perfusion with plasma-activated saline for bladder cancer; the trial is not yet re…
-
CLINICAL_TRIALS research · 2025-12-09Clinical Trial Update: Therapeutic Plasma Exchange With Enfortumab Vedotin and Pembrolizumab for Treatment of Bladder Cancers [Phase 2]
Phase 2 trial evaluating therapeutic plasma exchange in combination with enfortumab vedotin and pembrolizumab for metastatic bladder urothel…
-
CLINICAL_TRIALS research · 2025-12-09Clinical Trial Update: Effectiveness of a Personalized 6-month Programme on Frailty in Older Patients Treated for Bladder or Kidney Cancer. [NA]
This clinical trial update describes a personalized six-month program aimed at reducing frailty in older patients treated for bladder cancer…
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Trop2-targeted immunoPET Imaging of Solid Tumors [Phase 2, Phase 3]
Clinical trial update for Trop2-targeted immunoPET imaging of solid tumors, currently in Phase 2/3 and recruiting.
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Evaluation of Non-Invasive Assays for the Detection of Urothelial Cancer
This clinical trial is evaluating non-invasive assays for detecting urothelial cancer, with recruitment currently ongoing. The study is spon…
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes
This clinical trial update reports that City of Hope Medical Center's remote telemonitoring study of patient-generated physiological data an…
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: DRG Mutations in Prostate Cancer: a Guiding Light for Enhanced Screening and Personalised Therapy
This clinical trial update describes an ongoing study led by Istituto Clinico Humanitas investigating DRG gene mutations as a guide for enha…
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid Tumors [Phase 1]
Phase 1 study of TBI-1301, an NY-ESO-1–specific TCR gene-transduced autologous T cell therapy, in solid tumors; the trial is currently activ…
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Entinostat & Chemotherapy for Locally Advanced or Metastatic Bladder Cancer [Phase 1, Phase 2]
A phase 1/2 clinical trial is evaluating entinostat in combination with chemotherapy for locally advanced or metastatic bladder cancer. Recr…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating Mutations [Phase 2, Phase 3]
The DETERMINE trial update investigates the combination of Trastuzumab and Pertuzumab for HER2-amplified or activating-mutant cancers in adu…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: The Combined Role of FAPI PET and Liquid Biopsy in the Staging and Clinical Management of Bladder Cancer - FUTURE Trial [Phase 2]
The FUTURE trial (Phase 2) investigates using FAPI PET imaging together with liquid biopsy to stage and guide management of bladder cancer. …
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Women With isoLated acUte cyStitis and Macroscopic Hematuria. Is Further Investigation Needed?
A recruiting clinical trial in women with isolated acute cystitis and macroscopic hematuria to evaluate the need for further investigation o…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Hyperthermic Intravesical Chemotherapy (HIVEC) in BCG-Non-Responsive High-Grade NMIBC Patients [NA]
A clinical trial update describing Hyperthermic Intravesical Chemotherapy (HIVEC) for high-grade non-muscle invasive bladder cancer that is …
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Interest of Late Images for the Assessment of Extensions in 18FGD PET-CT of Muscle-Invasive Bladder Cancers [NA]
A recruiting clinical trial evaluating whether late 18F-FDG PET-CT imaging improves assessment of tumor extensions in muscle-invasive bladde…
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Home Intravenous Fluid Infusion After Undergoing Radical Cystectomy [NA]
Clinical trial entry from Johns Hopkins University recruiting to study home intravenous fluid infusion after radical cystectomy for bladder …
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Atezolizumab After Chemo-radiotherapy for MIBC Patients Not Eligible for Radical Cystectomy [Phase 2]
Phase 2 study of atezolizumab after chemo-radiotherapy for muscle-invasive bladder cancer patients who are not eligible for radical cystecto…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Multiparametric Magnetic Resonance Imaging (MRI) to Improve Bladder Cancer Staging and Treatment Decision-making [NA]
Completed clinical trial evaluating multiparametric MRI to improve bladder cancer staging and guide treatment decisions.
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Evaluating Safety and Efficacy of Prostate-sparing Radical Cystectomy [NA]
This clinical trial update describes ongoing recruitment for evaluating the safety and efficacy of a prostate-sparing radical cystectomy. Th…
-
CLINICAL_TRIALS research · 2025-11-14Clinical Trial Update: SeqUential GeMcitabine and MITomycin Treatment for Favorable High-Risk Upper Urinary Tract Urothelial Carcinoma [Phase 2]
This is a Phase 2 clinical trial from Rutgers evaluating sequential gemcitabine and mitomycin for favorable high‑risk upper tract urothelial…